4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FDMT 4D Molecular Therapeutics

盘前交易 05-09 07:39:25 EDT

26.33

-0.47

-1.75%

最高26.78	最低25.88	成交量34.01万
今开26.26	昨收26.80	日振幅3.36%
总市值13.47亿	流通市值8.65亿	总股本5,116万
成交额894.53万	换手率1.04%	流通股本3,285万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FDMT","market":"US","secType":"STK","nameCN":"4D Molecular Therapeutics","latestPrice":26.33,"timestamp":1715198400000,"preClose":26.8,"halted":0,"volume":340145,"delay":0,"floatShares":32854760,"shares":51157472,"eps":-2.576969,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.47,"latestTime":"05-09 07:39:25 EDT","open":26.26,"high":26.78,"low":25.88,"amount":8945331.17439,"amplitude":0.033582,"askPrice":31.09,"askSize":100,"bidPrice":23.37,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.576969,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715261400000},"adr":0,"listingDate":1607662800000,"adjPreClose":26.33,"postHourTrading":{"tag":"盘后","latestPrice":26.33,"preClose":26.33,"latestTime":"17:57 EDT","volume":55495,"amount":1461182.57,"timestamp":1715205439470},"volumeRatio":0.780766533068158},"requestUrl":"/m/hq/s/FDMT","defaultTab":"news","newsList":[{"id":"2432977092","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘大幅拉升5.53%报27.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432977092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432977092?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743214,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.53%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为69.18%、22.21%、11.11%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213335861ead45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213335861ead45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432835638","title":"4D Molecular Therapeutics, Inc.盘中异动 下午盘股价大涨5.06%报25.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432835638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432835638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:06","pubTimestamp":1714586811,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时06分，4D Molecular Therapeutics, Inc.股票出现异动，股价急速上涨5.06%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1401.54%、840.78%、249.77%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、84.43%、77.43%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050202065287e85358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050202065287e85358&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431628428","title":"4D Molecular Therapeutics, Inc.盘中异动 快速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431628428","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431628428?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:23","pubTimestamp":1714400632,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时23分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅上涨5.20%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为894.61%、35.93%、18.56%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Immunitybio, Inc.，振幅分别为33.33%、31.06%、29.01%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292223527924f388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292223527924f388&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430868712","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430868712","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430868712?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:37","pubTimestamp":1714052271,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时37分，4D Molecular Therapeutics, Inc.股票出现异动，股价大幅跳水5.07%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为877.70%、182.86%、7.06%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、25.31%、14.75%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213752861e9096&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213752861e9096&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429430929","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大涨6.60%报26.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429430929","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429430929?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:30","pubTimestamp":1713792659,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时30分，4D Molecular Therapeutics, Inc.股票出现波动，股价急速上涨6.60%。截至发稿，该股报26.92美元/股，成交量2578股，换手率0.01%，振幅0.00%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222131007a5491b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222131007a5491b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427884660","title":"美国研究综述-Blackstone、Coupang、富国银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2427884660","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427884660?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:46","pubTimestamp":1713203205,"startTime":"0","endTime":"0","summary":"    路透社4月15日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括黑石、Coupang 和富国银行。* Coupang Inc   ：花旗集团将其评级从中性上调至买入 * 联合太平洋公司  ：伯恩斯坦将其目标价从280美元上调至284美元 * 富国银行  ：Piper Sandler将目标价从56美元上调至61美元 以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427881280","title":"加拿大皇家银行：维持4D Molecular Therapeutics(FDMT.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427881280","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427881280?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:35","pubTimestamp":1713202544,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持4D Molecular Therapeutics(FDMT.US)评级，由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416013548878097b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416013548878097b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427000687","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427000687","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427000687?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:31","pubTimestamp":1713187862,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时31分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速上涨5.20%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Soligenix, Inc.、Organovo Holdings, Inc.、Longeveron Inc.涨幅较大，Allarity Therapeutics, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为578.18%、335.34%、251.73%，振幅较大的相关个股有Organovo Holdings, Inc.、Soligenix, Inc.、Vaxxinity, Inc.，振幅分别为20.79%、16.32%、9.83%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131028b263edf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152131028b263edf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426128686","title":"4D Molecular Therapeutics, Inc.盘中异动 股价大跌5.08%报27.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426128686","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426128686?lang=zh_cn&edition=full","pubTime":"2024-04-10 03:28","pubTimestamp":1712690908,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日03时28分，4D Molecular Therapeutics, Inc.股票出现异动，股价快速下跌5.08%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Acrivon Therapeutics, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为490.27%、163.98%、151.06%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Nutriband Inc C/Wts 、Vbi Vaccines, Inc.，振幅分别为118.42%、87.27%、71.66%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc 是一家临床阶段基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041003282887e7eeed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041003282887e7eeed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416642315","title":"4D Molecular Therapeutics, Inc.盘中异动 早盘急速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416642315","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416642315?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:54","pubTimestamp":1709304845,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时54分，4D Molecular Therapeutics, Inc.股票出现波动，股价大幅拉升5.03%。4D Molecular Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Cardiff Oncology, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Biovie Inc.较为活跃，换手率分别为2490.38%、260.43%、103.22%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Carmell Corp C/Wts 12/07/2028 、Biovie Inc.，振幅分别为98.31%、71.25%、69.35%。4D Molecular Therapeutics, Inc.公司简介：4D Molecular Therapeutics Inc是一家临床阶段的基因治疗公司，从事使用靶向和进化的AAV载体开发候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122540579165f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122540579165f27&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416466531","title":"美国研究综述-Broadcom、纽约社区银行、TopBuild","url":"https://stock-news.laohu8.com/highlight/detail?id=2416466531","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416466531?lang=zh_cn&edition=full","pubTime":"2024-03-01 14:50","pubTimestamp":1709275809,"startTime":"0","endTime":"0","summary":"    路透社3月1日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括博通公司、纽约社区银行和 TopBuild。要闻             * 博通公司  ：奥本海默将目标价从1100美元上调至1500美元              * 纽约社区银行  ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。* TopBuild Corp   ：Benchmark将目标价从320美元上调至450美元  以下是路透社周五报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.4dmoleculartherapeutics.com","stockEarnings":[{"period":"1week","weight":0.037},{"period":"1month","weight":-0.0842},{"period":"3month","weight":-0.0212},{"period":"6month","weight":1.3828},{"period":"1year","weight":0.5193},{"period":"ytd","weight":0.2996}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"4D Molecular Therapeutics, Inc.于2015年3月11日根据特拉华州法律成立。该公司是一家临床阶段基因治疗公司，开创了利用其靶向和进化的AAV载体开发候选产品的先河。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.114674},{"month":2,"riseRate":0.25,"avgChangeRate":0.09912},{"month":3,"riseRate":0.75,"avgChangeRate":0.041874},{"month":4,"riseRate":0.25,"avgChangeRate":-0.130346},{"month":5,"riseRate":0.5,"avgChangeRate":-0.139172},{"month":6,"riseRate":0,"avgChangeRate":-0.063179},{"month":7,"riseRate":1,"avgChangeRate":0.130747},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.015275},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.104114},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.06274},{"month":11,"riseRate":0.666667,"avgChangeRate":0.644163},{"month":12,"riseRate":0.333333,"avgChangeRate":0.155196}],"exchange":"NASDAQ","name":"4D Molecular Therapeutics","nameEN":"4D Molecular Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"4D Molecular Therapeutics,FDMT,4D Molecular Therapeutics股票,4D Molecular Therapeutics股票老虎,4D Molecular Therapeutics股票老虎国际,4D Molecular Therapeutics行情,4D Molecular Therapeutics股票行情,4D Molecular Therapeutics股价,4D Molecular Therapeutics股市,4D Molecular Therapeutics股票价格,4D Molecular Therapeutics股票交易,4D Molecular Therapeutics股票购买,4D Molecular Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"4D Molecular Therapeutics(FDMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供4D Molecular Therapeutics(FDMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}